Enemark, M.B.; Hybel, T.E.; Madsen, C.; Lauridsen, K.L.; Honoré, B.; Plesner, T.L.; Hamilton-Dutoit, S.; d’Amore, F.; Ludvigsen, M.
Tumor-Tissue Expression of the Hyaluronic Acid Receptor RHAMM Predicts Histological Transformation in Follicular Lymphoma Patients. Cancers 2022, 14, 1316.
https://doi.org/10.3390/cancers14051316
AMA Style
Enemark MB, Hybel TE, Madsen C, Lauridsen KL, Honoré B, Plesner TL, Hamilton-Dutoit S, d’Amore F, Ludvigsen M.
Tumor-Tissue Expression of the Hyaluronic Acid Receptor RHAMM Predicts Histological Transformation in Follicular Lymphoma Patients. Cancers. 2022; 14(5):1316.
https://doi.org/10.3390/cancers14051316
Chicago/Turabian Style
Enemark, Marie Beck, Trine Engelbrecht Hybel, Charlotte Madsen, Kristina Lystlund Lauridsen, Bent Honoré, Trine Lindhardt Plesner, Stephen Hamilton-Dutoit, Francesco d’Amore, and Maja Ludvigsen.
2022. "Tumor-Tissue Expression of the Hyaluronic Acid Receptor RHAMM Predicts Histological Transformation in Follicular Lymphoma Patients" Cancers 14, no. 5: 1316.
https://doi.org/10.3390/cancers14051316
APA Style
Enemark, M. B., Hybel, T. E., Madsen, C., Lauridsen, K. L., Honoré, B., Plesner, T. L., Hamilton-Dutoit, S., d’Amore, F., & Ludvigsen, M.
(2022). Tumor-Tissue Expression of the Hyaluronic Acid Receptor RHAMM Predicts Histological Transformation in Follicular Lymphoma Patients. Cancers, 14(5), 1316.
https://doi.org/10.3390/cancers14051316
